FDA Launches Re-Assessment of BHA, Publishes RFI Posted on February 11, 2026 On February 10, 2026, FDA announced the launch of a “comprehensive re-assessment of butylated hydroxyanisole (BHA)” to “consider whether BHA is safe under its current conditions of use in food … Continue Reading FDA Launches Re-Assessment of BHA, Publishes RFI
